<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; American Medical Systems Holdings Inc</title>
	<atom:link href="http://www.stockbloghub.com/tag/american-medical-systems-holdings-inc/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Sun, 20 May 2012 20:27:31 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(AMMD) American Medical Systems Starts Implant Registry</title>
		<link>http://www.stockbloghub.com/2011/06/20/ammd-american-medical-systems-starts-implant-registry/76861</link>
		<comments>http://www.stockbloghub.com/2011/06/20/ammd-american-medical-systems-starts-implant-registry/76861#comments</comments>
		<pubDate>Tue, 21 Jun 2011 04:15:55 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[American Medical Systems Holdings Inc]]></category>
		<category><![CDATA[AMMD]]></category>
		<category><![CDATA[BCR]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[Cr Bard Inc]]></category>
		<category><![CDATA[Endo Pharmaceuticals Holdings Inc]]></category>
		<category><![CDATA[ENDP]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=76861</guid>
		<description><![CDATA[Leading pelvic-health devices maker American Medical Systems (AMMD) recently initiated a large-scale global registry of penile prosthetic outcomes. The new registry, dubbed PROPPER (Prospective Registry of Outcomes with Penile Prosthesis for Erectile Restoration), is managed by a crew of eminent urologists looking to better characterize patient satisfaction associated with modern penile prosthetic implants. The multi-year company-sponsored PROPPER registry, essentially the first-of-its-kind, has been designed to better understand the real-world outcomes of penile implant surgery to treat erectile dysfunction (“ED”). The registry is expected to enroll more than 1,000 ED patients recommended for penile prosthesis by their physicians. The research, which will initially engage ten sites, will involve  a prospective measure of patient responses by investigating physicians at regular intervals (over a 1-5 year period) using questionnaires and electronic data collection. ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/06/20/ammd-american-medical-systems-starts-implant-registry/76861/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ENDP) Endo Pharmaceuticals Evenly Poised</title>
		<link>http://www.stockbloghub.com/2011/05/30/endp-endo-pharmaceuticals-evenly-poised/74362</link>
		<comments>http://www.stockbloghub.com/2011/05/30/endp-endo-pharmaceuticals-evenly-poised/74362#comments</comments>
		<pubDate>Mon, 30 May 2011 15:24:48 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Manufacturers - Other]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[American Medical Systems Holdings Inc]]></category>
		<category><![CDATA[AMMD]]></category>
		<category><![CDATA[Charles River Laboratories International Inc]]></category>
		<category><![CDATA[CRL]]></category>
		<category><![CDATA[Endo Pharmaceuticals Holdings Inc]]></category>
		<category><![CDATA[ENDP]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MYL]]></category>
		<category><![CDATA[Mylan Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=74362</guid>
		<description><![CDATA[We are maintaining our Neutral stance on Endo Pharmaceuticals (ENDP) with a target price of $44.00. Headquartered in Chadds Ford, Pennsylvania and founded in 1997, Endo Pharma is a specialty healthcare solutions company. The company, which operates in the US, reports results through three segments: Branded Pharmaceuticals, Generics and Devices and Services. Endo Pharma offers more than 175 products in the areas of pain management, urology and oncology. In April 2011, Endo Pharma reported its first quarter 2011 results. First quarter adjusted earnings of $1.00 per share were in line with the Zacks Consensus Estimate but $0.26 above the year ago figure. The year-over-year rise in earnings was attributable to the higher revenues reported in the first quarter of 2011. We note that Endo Pharma is on an acquisition spree ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/05/30/endp-endo-pharmaceuticals-evenly-poised/74362/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(AMMD) American Medical Systems Analyst Maintains Neutral Rating on Shares</title>
		<link>http://www.stockbloghub.com/2011/05/10/ammd-american-medical-systems-analyst-maintains-neutral-rating-on-shares/73777</link>
		<comments>http://www.stockbloghub.com/2011/05/10/ammd-american-medical-systems-analyst-maintains-neutral-rating-on-shares/73777#comments</comments>
		<pubDate>Tue, 10 May 2011 21:01:15 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[American Medical Systems Holdings Inc]]></category>
		<category><![CDATA[AMMD]]></category>
		<category><![CDATA[BCR]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[Cr Bard Inc]]></category>
		<category><![CDATA[Endo Pharmaceuticals Holdings Inc]]></category>
		<category><![CDATA[ENDP]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=73777</guid>
		<description><![CDATA[We maintain our Neutral recommendation on leading pelvic-health devices maker American Medical Systems (AMMD). Its first-quarter fiscal 2011 earnings of 33 cents per share beat the Zacks Consensus Estimate of 30 cents. Both revenues and profit rose roughly 4% year over year on the back of higher sales from the Minnesota-based company’s men’s health and women’s health businesses, assisted by a healthy contribution from its international operation. Sales (of $140.8 million) for the quarter also beat the Zacks Consensus Estimate. American Medical’s men’s health division remained on the growth track supported by the strength at its male continence business. Its benign prostatic hyperplasia (“BPH”) therapy business posted healthy growth in the quarter, led by the GreenLight XPS laser therapy and the next-generation BPH therapy system MoXy Liquid Cooled Fiber. The ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/05/10/ammd-american-medical-systems-analyst-maintains-neutral-rating-on-shares/73777/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ENDP) Endo Pharmaceuticals Holdings to Take Over American Medical Systems</title>
		<link>http://www.stockbloghub.com/2011/04/12/endp-endo-pharmaceuticals-holdings-to-take-over-american-medical-systems/71287</link>
		<comments>http://www.stockbloghub.com/2011/04/12/endp-endo-pharmaceuticals-holdings-to-take-over-american-medical-systems/71287#comments</comments>
		<pubDate>Tue, 12 Apr 2011 20:33:06 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Manufacturers - Other]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[American Medical Systems Holdings Inc]]></category>
		<category><![CDATA[AMMD]]></category>
		<category><![CDATA[Endo Pharmaceuticals Holdings Inc]]></category>
		<category><![CDATA[ENDP]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=71287</guid>
		<description><![CDATA[In a bid to diversify its business and bolster its urology portfolio, Endo Pharmaceuticals Holdings Inc. (ENDP), a US-based specialty healthcare solutions company which develops branded products and specialty generics, will purchase American Medical Systems (AMMD), a leading pelvic-health devices provider, for $2.9 billion or $30.00 per share in cash. The offer price is 34% above the April 8, 2011, closing price of American Medical. The $2.9 billion consideration includes the assumption of a $312 million debt by Endo Pharma. The deal, expected to close in the third quarter of 2011, has been approved by the boards of both companies. Endo Pharma anticipates the deal to be accretive to its adjusted earnings with immediate effect following closure. Moreover, the deal is expected to boost Endo Pharma’s 2012 and 2013 adjusted ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/04/12/endp-endo-pharmaceuticals-holdings-to-take-over-american-medical-systems/71287/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(AA) Company News for April 12, 2011 &#8211; Corporate Summary</title>
		<link>http://www.stockbloghub.com/2011/04/12/aa-company-news-for-april-12-2011-corporate-summary/71270</link>
		<comments>http://www.stockbloghub.com/2011/04/12/aa-company-news-for-april-12-2011-corporate-summary/71270#comments</comments>
		<pubDate>Tue, 12 Apr 2011 17:57:19 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Aluminum]]></category>
		<category><![CDATA[Basic Materials]]></category>
		<category><![CDATA[AA]]></category>
		<category><![CDATA[Alcoa Inc.]]></category>
		<category><![CDATA[American Medical Systems Holdings Inc]]></category>
		<category><![CDATA[AMMD]]></category>
		<category><![CDATA[BHP]]></category>
		<category><![CDATA[Bhp Billiton Limited]]></category>
		<category><![CDATA[BIIB]]></category>
		<category><![CDATA[Biogen Idec Inc]]></category>
		<category><![CDATA[Community Health Systems Inc.]]></category>
		<category><![CDATA[CYH]]></category>
		<category><![CDATA[Endo Pharmaceuticals Holdings Inc]]></category>
		<category><![CDATA[ENDP]]></category>
		<category><![CDATA[FLO]]></category>
		<category><![CDATA[Flowers Foods Inc.]]></category>
		<category><![CDATA[GLBC]]></category>
		<category><![CDATA[Global Crossing Limited]]></category>
		<category><![CDATA[JPM]]></category>
		<category><![CDATA[JPMorgan Chase & Company]]></category>
		<category><![CDATA[Level 3 Communications Inc.]]></category>
		<category><![CDATA[LVLT]]></category>
		<category><![CDATA[Tasty Baking Company]]></category>
		<category><![CDATA[Tenet Healthcare Corporation]]></category>
		<category><![CDATA[THC]]></category>
		<category><![CDATA[TSTY]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=71270</guid>
		<description><![CDATA[• Level 3 Communications (NASDAQ:LVLT) and Global Crossing Limited (NASDAQ:GLBC) have entered into a agreement under which Level 3 will acquire Global Crossing in a stock-for-stock transaction • Endo Pharmaceuticals&#8217; (NASDAQ:ENDP) said that it would buy urological medical device supplier American Medical Systems (NASDAQ:AMMD) for about $2.6 billion • Alcoa (NYSE:AA) reported Q1 EPS of $0.28, ex-items, ahead of the Zacks Consensus Estimate of $0.27 per share. Revenues for the quarter rose 22% year-over-year to $6.0 billion, lower than the Zacks Consensus Estimate of $6.112 billion • Share prices of Molycorp, Inc. (NYSE:MCP) increased 5% after JP Morgan (NYSE:JPM) raised its target price to $90 from $74 • Credit Suisse upgraded BHP Billiton (NYSE:BHP) to ‘Outperform’ from ‘Neutral’ rating. Share prices of BHP Billiton gained 1.34% to close at $102.68 • Flowers Food Inc. (NYSE:FLO) said ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/04/12/aa-company-news-for-april-12-2011-corporate-summary/71270/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(AMMD) American Medical Systems Quarterly Report Beats Forecasts</title>
		<link>http://www.stockbloghub.com/2011/02/18/ammd-american-medical-systems-quarterly-report-beats-forecasts/67104</link>
		<comments>http://www.stockbloghub.com/2011/02/18/ammd-american-medical-systems-quarterly-report-beats-forecasts/67104#comments</comments>
		<pubDate>Fri, 18 Feb 2011 16:45:20 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[American Medical Systems Holdings Inc]]></category>
		<category><![CDATA[AMMD]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=67104</guid>
		<description><![CDATA[Leading pelvic-health devices provider American Medical Systems (AMMD) posted fourth-quarter fiscal 2010 adjusted (excluding one-time items such as amortization charges) earnings per share of 40 cents, ahead of the Zacks Consensus Estimate of 36 cents while exceeding the year-ago adjusted earnings of 35 cents. The results also beat the Minnesota-based company’s guidance range of 35 to 38 cents. Profit for the quarter climbed 16.7% year over year to $27.2 million (or 35 cents a share). For fiscal 2010, adjusted earnings of $1.30 a share also beat the Zacks Consensus Estimate of $1.25 and surpassed the year-ago earnings of $1.16. Besides, amortization charges, the full year adjusted earnings also exclude gains from the divestiture of the company’s “Her Option” uterine health product line. Revenues and Margins Revenues for the quarter edged ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/02/18/ammd-american-medical-systems-quarterly-report-beats-forecasts/67104/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(AMMD) American Medical Systems Maintains Neutral on Shares</title>
		<link>http://www.stockbloghub.com/2010/12/13/ammd-american-medical-systems-maintains-neutral-on-shares/59624</link>
		<comments>http://www.stockbloghub.com/2010/12/13/ammd-american-medical-systems-maintains-neutral-on-shares/59624#comments</comments>
		<pubDate>Mon, 13 Dec 2010 16:07:59 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[American Medical Systems Holdings Inc]]></category>
		<category><![CDATA[AMMD]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=59624</guid>
		<description><![CDATA[We maintain our Neutral recommendation on leading pelvic-health devices maker American Medical Systems (AMMD). Earnings for third-quarter fiscal 2010 beat the Zacks Consensus Estimate by a penny while profit plummeted 35% year over year as the year-ago profit was boosted by one-time gains from asset sale and extinguishment of debt. Revenuesimproved narrowly year over year while missing the Zacks Consensus Estimate. Sales were impacted by an unfavorable foreign exchange translation and a soft U.S. economy. American Medical’s Men’s Health segment revenues rose marginally as higher sales from male continence product lines were partly marred by a relatively flat erectile restoration business. Sustained healthy performance of pelvic floor repair products fueled a 6% revenue growth at the company’s Women’s Health division. Minnesota-based American Medical is a world leader in manufacturing medical ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/12/13/ammd-american-medical-systems-maintains-neutral-on-shares/59624/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(AMMD) American Medical Systems Announces Positive Data for Pelvic Repair System</title>
		<link>http://www.stockbloghub.com/2010/09/23/ammd-american-medical-systems-announces-positive-data-for-pelvic-repair-system/52544</link>
		<comments>http://www.stockbloghub.com/2010/09/23/ammd-american-medical-systems-announces-positive-data-for-pelvic-repair-system/52544#comments</comments>
		<pubDate>Thu, 23 Sep 2010 15:14:26 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[American Medical Systems Holdings Inc]]></category>
		<category><![CDATA[AMMD]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=52544</guid>
		<description><![CDATA[Leading pelvic-health devices provider American Medical Systems (AMMD) has announced encouraging clinical study results for its Elevate Apical and Posterior vaginal prolapse (or pelvic organ prolapse) repairing system. The company has published the results at the 2010 annual meeting of the International Urogynecological Association (IUGA) and International Continence Society (ICS). The 12-month study, which was conducted at sixteen centers across the U.S., Canada, Belgium and UK demonstrated encouraging safety and efficacy data of the Elevate system. Data shows an efficacy rate of 89.2% for Apical and 91.7% for Posterior, manifesting the procedure’s effectiveness in restoring pelvic anatomy and improving quality of life. Moreover, the results also establish that 98.4% of the treated patients would recommend the Elevate system to a friend. The procedure appeared to be safe with low morbidity ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/09/23/ammd-american-medical-systems-announces-positive-data-for-pelvic-repair-system/52544/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(AMMD) American Medical Systems&#8217; Analyst Maintains Neutral Rating</title>
		<link>http://www.stockbloghub.com/2010/08/16/ammd-american-medical-systems-analyst-maintains-neutral-rating/48130</link>
		<comments>http://www.stockbloghub.com/2010/08/16/ammd-american-medical-systems-analyst-maintains-neutral-rating/48130#comments</comments>
		<pubDate>Mon, 16 Aug 2010 19:45:21 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[American Medical Systems Holdings Inc]]></category>
		<category><![CDATA[AMMD]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[SUI]]></category>
		<category><![CDATA[Sun Communities Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=48130</guid>
		<description><![CDATA[We reiterate our Neutral recommendation on leading pelvic-health devices maker American Medical Systems (AMMD). Earnings for second-quarter fiscal 2010 beat the Zacks Consensus Estimate by a penny while profit soared 22% year-over-year on account of higher sales that spiked roughly 8% in the quarter. However, sales narrowly missed the Zacks Consensus Estimate. American Medical’s Men’s Health segment posted 7.7% year-over-year revenue growth, boosted by higher demand for the erectile restoration and male continence product lines. Its Women’s Health business delivered mid-teen revenue growth buoyed by higher sales of pelvic floor repair products. American Medical reaffirmed its fiscal 2010 revenue and earnings forecasts. Minnesota-based American Medical is a world leader in manufacturing medical devices and procedures for treating health problems of both men and women. In addition to the U.S., the company ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/08/16/ammd-american-medical-systems-analyst-maintains-neutral-rating/48130/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(AMMD) American Medical Systems AdVance XP Gets CE Mark</title>
		<link>http://www.stockbloghub.com/2010/08/10/ammd-american-medical-systems-advance-xp-gets-ce-mark/47467</link>
		<comments>http://www.stockbloghub.com/2010/08/10/ammd-american-medical-systems-advance-xp-gets-ce-mark/47467#comments</comments>
		<pubDate>Wed, 11 Aug 2010 01:28:39 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[American Medical Systems Holdings Inc]]></category>
		<category><![CDATA[AMMD]]></category>
		<category><![CDATA[BCR]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[Cr Bard Inc]]></category>
		<category><![CDATA[SUI]]></category>
		<category><![CDATA[Sun Communities Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=47467</guid>
		<description><![CDATA[Leading pelvic-health devices maker American Medical Systems (AMMD) reported that it received the European CE mark for its AdVance XP sling system for the treatment of male stress urinary incontinence (SUI). AdVance XP is the next-generation successor to American Medical’s AdVance (launched in August 2006) minimally invasive sling system for mild SUI. Male SUI, which is characterized by an involuntary loss of urine, affects roughly 5 million men in the U.S. It is a common side effect of prostate cancer and benign prostatic hyperplasia (enlarged prostate) treatments such as prostatectomy (surgical removal of the prostate) and transurethral resection of the prostate (TURP). The condition is often caused by prostate abnormality, urinary tract infection, neurological disorders and aging. Slings are the most commonly used surgical procedure for SUI. It typically consists ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/08/10/ammd-american-medical-systems-advance-xp-gets-ce-mark/47467/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(AMMD) American Medical Systems Beat Forecasts by a Sliver</title>
		<link>http://www.stockbloghub.com/2010/08/06/ammd-american-medical-systems-beat-forecasts-by-a-sliver/46724</link>
		<comments>http://www.stockbloghub.com/2010/08/06/ammd-american-medical-systems-beat-forecasts-by-a-sliver/46724#comments</comments>
		<pubDate>Fri, 06 Aug 2010 17:02:13 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[American Medical Systems Holdings Inc]]></category>
		<category><![CDATA[AMMD]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[SUI]]></category>
		<category><![CDATA[Sun Communities Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=46724</guid>
		<description><![CDATA[Leading pelvic-health device provider American Medical Systems (AMMD) reported second-quarter fiscal 2010 adjusted (excluding amortization charges) earnings per share of 31 cents, beating the Zacks Consensus Estimate by a penny while leaping ahead of the year-ago earnings of 29 cents. The results dovetail with the company’s expectation of 29 to 31 cents. Net income shot up 22% year over year to $20.6 million (or 26 cents a share), pushed by higher sales. Revenues Revenues spiked 7.9% (7.6% in constant currency) year over year to $136.4 million, narrowly missing the Zacks Consensus Estimate of $137 million. Revenues were impacted by an unfavorable foreign currency translation. Segment Analysis By business segments, Men’s Health sales leapt 7.7% year over year to $61.4 million, boosted by higher demand for the erectile restoration and male ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/08/06/ammd-american-medical-systems-beat-forecasts-by-a-sliver/46724/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(AMMD) American Medical Systems Announces Positive Data for MiniArc</title>
		<link>http://www.stockbloghub.com/2010/07/15/ammd-american-medical-systems-announces-positive-data-for-miniarc/43577</link>
		<comments>http://www.stockbloghub.com/2010/07/15/ammd-american-medical-systems-announces-positive-data-for-miniarc/43577#comments</comments>
		<pubDate>Thu, 15 Jul 2010 21:20:57 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[American Medical Systems Holdings Inc]]></category>
		<category><![CDATA[AMMD]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[SUI]]></category>
		<category><![CDATA[Sun Communities Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=43577</guid>
		<description><![CDATA[Leading pelvic-health device provider American Medical Systems (AMMD) has announced encouraging clinical trial results for its MiniArc single-incision sling system as a first-line treatment for female stress urinary incontinence (SUI). The company has published the positive data from the trial in the Journal of Urology, the official journal of the American Urological Association (AUA). The 12-month study, which was conducted at sixteen centers across the U.S. , Canada , Belgium and UK , reveals long-term safety, efficacy and patient convenience/tolerance of the MiniArc sling system. Data shows a success rate of 90% for the device in terms of efficacy and its ability to improve a patient’s quality of life by mitigating tissue trauma and offering fast recovery. The trial results further validate MiniArc’s potential as a safe and effective treatment ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/07/15/ammd-american-medical-systems-announces-positive-data-for-miniarc/43577/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(AMMD) American Medical Systems Holdings Outperforms The Street</title>
		<link>http://www.stockbloghub.com/2010/05/09/ammd-american-medical-systems-holdings-outperforms-the-street/36590</link>
		<comments>http://www.stockbloghub.com/2010/05/09/ammd-american-medical-systems-holdings-outperforms-the-street/36590#comments</comments>
		<pubDate>Sun, 09 May 2010 20:07:21 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[American Medical Systems Holdings Inc]]></category>
		<category><![CDATA[AMMD]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=36590</guid>
		<description><![CDATA[American Medical Systems Holdings, Inc. (AMMD) reported fiscal first-quarter earnings per share of 29 cents, outperforming both the Zacks Consensus Estimate and the year-ago earnings of 25 cents. EPS results came in higher than the company’s own expectations of 23 to 26 cents. Sales Total revenues in the first quarter increased 9.1% year over year to $134.9 million. Excluding a favorable foreign currency translation, net sales increased 7.1% year over year. In terms of business segments: Men’s Health sales increased 8.4% year over year to $64.5 million. Growth was primarily due to higher demand for the Erectile Restoration product line, partly offset by lower demand for Male Continence products. Women’s Health revenues increased 17.8% year over year to $42.7 million. Growth can be primarily attributed to higher sales of Pelvic Floor Repair ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/05/09/ammd-american-medical-systems-holdings-outperforms-the-street/36590/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(AMMD) American Medical Systems Holdings Analysts Maintain Neutral Rating</title>
		<link>http://www.stockbloghub.com/2010/03/27/ammd-american-medical-systems-holdings-analysts-maintain-neutral-rating/32003</link>
		<comments>http://www.stockbloghub.com/2010/03/27/ammd-american-medical-systems-holdings-analysts-maintain-neutral-rating/32003#comments</comments>
		<pubDate>Sat, 27 Mar 2010 20:50:23 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[American Medical Systems Holdings Inc]]></category>
		<category><![CDATA[AMMD]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=32003</guid>
		<description><![CDATA[We recently reiterated our ‘Neutral’ recommendation on American Medical Systems Holdings, Inc. (AMMD) with a target price of $20 based on a P/E of approximately 16.4x our fiscal 2010 EPS estimate of $1.22. American Medical reported fourth-quarter earnings per share of 35 cents, surpassing the Zacks Consensus Estimate of 34 cents and the year-ago earnings of 26 cents. For fiscal 2009, earnings per share were $1.09, ahead of 70 cents, a year-ago. Total revenue in the fourth quarter increased 9% year over year to $146 million. Excluding a favorable foreign currency translation (FX), net sales increased 6.1% year over year. In terms of business segments: Men’s Health sales increased 8.2% year over year to $63.5 million. Growth was primarily due to higher demand for the Erectile Restoration product line, partly ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/03/27/ammd-american-medical-systems-holdings-analysts-maintain-neutral-rating/32003/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(AMMD) American Medical Systems Holdings Reports Strong Earnings</title>
		<link>http://www.stockbloghub.com/2010/02/23/ammd-american-medical-systems-holdings-reports-strong-earnings/28504</link>
		<comments>http://www.stockbloghub.com/2010/02/23/ammd-american-medical-systems-holdings-reports-strong-earnings/28504#comments</comments>
		<pubDate>Wed, 24 Feb 2010 03:20:17 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[American Medical Systems Holdings Inc]]></category>
		<category><![CDATA[AMMD]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=28504</guid>
		<description><![CDATA[American Medical Systems Holdings, Inc. (AMMD) reported strong fourth quarter and full fiscal 2009 results. For the fourth quarter, earnings per share were 35 cents, surpassing the Zacks Consensus Estimate of 34 cents and the year-ago earnings of 30 cents. For fiscal 2009, earnings per share were $1.16, ahead of the year-ago figure of 88 cents. Quarterly results Total revenues in the fourth quarter increased 9.0% year over year to $146.0 million. Excluding a favorable foreign currency translation (FX), net sales increased 6.1% year over year. In terms of business segments: Men’s Health sales increased 8.2% year over year to $63.5 million. Growth was primarily due to higher demand for the Erectile Restoration product line, partly offset by lower demand for Male Continence products. Women’s Health revenues increased 8.9% year ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/02/23/ammd-american-medical-systems-holdings-reports-strong-earnings/28504/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(AMMD) American Medical Systems Holdings Earns New Agreement</title>
		<link>http://www.stockbloghub.com/2010/02/01/ammd-american-medical-systems-holdings-earns-new-agreement/26606</link>
		<comments>http://www.stockbloghub.com/2010/02/01/ammd-american-medical-systems-holdings-earns-new-agreement/26606#comments</comments>
		<pubDate>Mon, 01 Feb 2010 22:52:12 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[American Medical Systems Holdings Inc]]></category>
		<category><![CDATA[AMMD]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=26606</guid>
		<description><![CDATA[American Medical Systems Holdings, Inc. (AMMD) recently entered into a new agreement with Tissue Genesis, Inc., an emerging leader in advanced tissue engineering and cell therapy solutions, for the research and development of adipose (fat) derived regenerative cells for use in treating pelvic health disorders. Per the agreement, American Medical has a four year option to obtain exclusive distribution and license rights to Tissue Genesis&#8217; regenerative cell technology Incorporatedluding the Tissue Genesis Cell Isolation System for use in human pelvic health applications, with an additional two year right of first refusal. American Medical will pay $1.1 million to Tissue Genesis to obtain these rights. Tissue Genesis will also provide American Medical with instruments, disposables, and know-how to allow American Medical to develop state-of-the-art regenerative cell applications. Headquartered in Minnetonka, Minnesota ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/02/01/ammd-american-medical-systems-holdings-earns-new-agreement/26606/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(AMMD) American Medical Systems Holdings Reports Strong Preliminary Report</title>
		<link>http://www.stockbloghub.com/2010/01/13/ammd-american-medical-systems-holdings-reports-strong-preliminary-report/24852</link>
		<comments>http://www.stockbloghub.com/2010/01/13/ammd-american-medical-systems-holdings-reports-strong-preliminary-report/24852#comments</comments>
		<pubDate>Wed, 13 Jan 2010 17:41:44 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[American Medical Systems Holdings Inc]]></category>
		<category><![CDATA[AMMD]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=24852</guid>
		<description><![CDATA[American Medical Systems Holdings, Inc. (AMMD) reported strong preliminary revenues for the fourth quarter and full fiscal 2009. For the fourth quarter, total revenues were $146.0 million, an increase of 9% year over year. Excluding a favorable foreign exchange translation (FX), net sales increased 6.1% year over year. Total revenues in the fourth quarter were ahead of American Medical’s previous guidance of $136 million to $142 million. For full fiscal 2009, American Medical Systems reported total revenues of $519.3 million, an increase of 3.5% year over year. Excluding an unfavorable FX, net sales increased 5.2% year over year. In the fourth quarter, sales growth was witnessed across all business segments. Men’s Health sales increased 8.2% year over year to $63.5 million. Growth was primarily due to strong demand for the ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/01/13/ammd-american-medical-systems-holdings-reports-strong-preliminary-report/24852/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>($AMMD) American Medical Systems Holdings Reports Strong</title>
		<link>http://www.stockbloghub.com/2009/11/07/ammd-american-medical-systems-holdings-reports-strong/19821</link>
		<comments>http://www.stockbloghub.com/2009/11/07/ammd-american-medical-systems-holdings-reports-strong/19821#comments</comments>
		<pubDate>Sun, 08 Nov 2009 00:37:54 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[American Medical Systems Holdings Inc]]></category>
		<category><![CDATA[AMMD]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=19821</guid>
		<description><![CDATA[American Medical Systems Holdings, Inc. (AMMD) reported strong fiscal third quarter results. For the quarter, earnings per share was 27 cents, beating the Zacks Consensus Estimate of 20 cents and the year-ago earnings of 18 cents. Earnings per share for the reported quarter were also ahead of the company’s previous guidance of 17 to 21 cents. Sales Total sales for the quarter increased 4.9% year over year to $123.2 million. Excluding an unfavorable foreign currency translation (FX), net sales increased 6.7% year over year. On a geographic basis, U.S. sales accounted for roughly 75% of total sales and increased 9.2% year over year. International sales declined 6.1% year over year. In terms of business segments: Men’s health revenues increased 6.6% year over year to $54.7 million. Growth was primarily due ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/11/07/ammd-american-medical-systems-holdings-reports-strong/19821/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(AMMD) American Medical Systems Sells Ovion Technology</title>
		<link>http://www.stockbloghub.com/2009/10/12/ammd-american-medical-systems-sells-ovion-technology/17372</link>
		<comments>http://www.stockbloghub.com/2009/10/12/ammd-american-medical-systems-sells-ovion-technology/17372#comments</comments>
		<pubDate>Mon, 12 Oct 2009 17:11:30 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[American Medical Systems Holdings Inc]]></category>
		<category><![CDATA[AMMD]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[Conceptus Inc]]></category>
		<category><![CDATA[CPTS]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=17372</guid>
		<description><![CDATA[American Medical Systems (AMMD) recently announced that it has agreed to sell its female sterilization assets and technology to Conceptus Inc. (CPTS). Under the $23.6 million cash deal, Conceptus acquired all patents and intellectual property associated with the Ovion business, which was acquired by American Medical Systems in July 2005. American Medical Systems acquired Ovion Inc. to further broaden its gynecology franchise. Ovion, a pre-commercialization company, developed an office-based technology for the delivery of a permanent birth control solution for women. Conceptus intends to make use of the Ovion technology to develop future versions of its Essure permanent female contraceptive. Essure, a non-incisional permanent birth control method, received approval from the U.S. Food and Drug Administration (FDA) in 2002. Under the terms of the present agreement, Conceptus will not be ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/10/12/ammd-american-medical-systems-sells-ovion-technology/17372/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(AMMD) American Medical Systems Holdings: Positive Clinical Data</title>
		<link>http://www.stockbloghub.com/2009/10/03/ammd-american-medical-systems-holdings-positive-clinical-data/16492</link>
		<comments>http://www.stockbloghub.com/2009/10/03/ammd-american-medical-systems-holdings-positive-clinical-data/16492#comments</comments>
		<pubDate>Sat, 03 Oct 2009 22:02:32 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[American Medical Systems Holdings Inc]]></category>
		<category><![CDATA[AMMD]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[SUI]]></category>
		<category><![CDATA[Sun Communities Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=16492</guid>
		<description><![CDATA[American Medical Systems Holdings, Inc. (AMMD) recently announced positive results from three major clinical studies that demonstrated high efficiency and patient satisfaction with the company’s minimally invasive treatment options for female stress urinary incontinence (SUI) and vaginal prolapse. The results also demonstrated low post-operative pain and a low incidence of adverse events for patients. The clinical studies were concentrated on three products – the MiniArc Single-Incision Sling System for treating female SUI, the Elevate Prolapse Repair System and the Perigee Prolapse Repair System. Results for each of these studies are presented here: Six-month prospective evaluation of the MiniArc Single-Incision Sling System – The device delivered 91% success rate with the preliminary results pointing towards minimal estimated blood loss, minimal length of hospital stay and short operative times. American Medical Systems ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/10/03/ammd-american-medical-systems-holdings-positive-clinical-data/16492/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

